EPA Plans to Discontinue a Senior Science Advisor Position
EPA Plans to Discontinue a Senior Science Advisor Position
This change is part of an overhaul taking placing within the research arm of the environmental agency.
EPA Plans to Discontinue a Senior Science Advisor Position
EPA Plans to Discontinue a Senior Science Advisor Position

This change is part of an overhaul taking placing within the research arm of the environmental agency.

This change is part of an overhaul taking placing within the research arm of the environmental agency.

research and development
Trump Releases Science Spending Priorities for FY2019
Trump Releases Science Spending Priorities for FY2019
Aggie Mika | Aug 18, 2017
In a memo to federal agencies, the administration highlights defense and security, leaves off Earth and climate science, and limits the scope of basic research.
Alphabet Announces Life Sciences
Alphabet Announces Life Sciences
Tracy Vence | Aug 24, 2015
Google’s parent company is launching a research-and-development project as a standalone firm.
Layoffs, Restructuring at GSK
Layoffs, Restructuring at GSK
Tracy Vence | Dec 4, 2014
GlaxoSmithKline is eliminating 900 US jobs—most in R&D.
Study: Drug Development Costs $2.6B
Study: Drug Development Costs $2.6B
Kerry Grens | Nov 24, 2014
A new estimate finds the pricetag for taking a drug through the approval process has steadily risen over the past few decades.
Opinion: Research, Restricted
Opinion: Research, Restricted
David Nutt | Jul 8, 2013
Are the international drug laws the worst impediment to scientific inquiry since the Catholic Church banned the telescope?
Building a Better Network
Building a Better Network
Jef Akst | Apr 23, 2013
NIH Director Francis Collins and colleagues announce plans to create a health-care research network to connect patients, doctors, and clinical researchers.
Gold Dust Missing from Pfizer Lab
Gold Dust Missing from Pfizer Lab
Jef Akst | Dec 10, 2012
$700,000 worth of gold dust has been reported missing from a Pfizer medical research lab in Missouri.
Medicines for the World
Suerie Moon and Ellen â??t Hoen, Suerie Moon and Ellen â??t Hoen | Oct 1, 2012
A global R&D treaty could boost innovation and improve the health of the world’s poor—and rich.
Pharma's Fake Innovation Crisis?
Bob Grant | Aug 13, 2012
Two medical professors contend that the pharmaceutical industry is really suffering from a drive to make only marginal improvements to existing drugs.